Physician profile
Daniel Eric Weiland
NPI 1821027244
$7,114.84
in general payments reported to CMS, 2019-2025
10 companies · $581 in 2025
The $581 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.25 · 2020: $42.94 · 2022: $4,490 · 2023: $875 · 2024: $1,045 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,500.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $3,640.00 | 2022 | |
| Depuy Synthes Sales INC. | $1,446.95 | 2020-2024 | Healix Knotless Peek, Vapr, Dynatape |
| Stryker Corporation | $917.82 | 2022-2024 | Blueprint Patient Specific Instrumentation |
| Linvatec Corporation | $295.21 | 2023 | Biobrace 23mm |
| Smith+Nephew, INC. | $278.66 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System |
| Polaris Technology Solutions LLC | $258.31 | 2023-2025 | |
| Saluda Medical Americas, INC. | $149.10 | 2025 | Evoke |
| Vericel Corporation | $93.85 | 2023-2025 | Maci |
| Medical Device Business Services, INC. | $18.54 | 2022 | |
| Geistlich Pharma, North America, INC. | $16.40 | 2024 | Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weiland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.